株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

RNA解析/トランスクリプトミクス市場:技術別(マイクロアレイ、PCR、NGS、RNAi)、用途別(臨床診断、創薬、毒性ゲノミクス)、エンドユーザー別(学術研究機関、製薬会社、バイオテクノロジー企業の世界市場予測

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

発行 MarketsandMarkets 商品コード 315354
出版日 ページ情報 英文 192 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
RNA解析/トランスクリプトミクス市場:技術別(マイクロアレイ、PCR、NGS、RNAi)、用途別(臨床診断、創薬、毒性ゲノミクス)、エンドユーザー別(学術研究機関、製薬会社、バイオテクノロジー企業の世界市場予測 RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
出版日: 2014年09月26日 ページ情報: 英文 192 Pages
概要

世界のトランスクリプトミクス市場は2013年に17億4,320万米ドルとなりました。同市場は2019年までCAGR13.7%で拡大しつづけ、37億7,300万米ドルに達すると予測されています。トランスクリプトミクス市場は過去数年、RNA解析研究におけるシーケンシング技術の応用や"オミクス"研究における技術的進歩によって、大きく成長してきました。

当レポートは、世界のRNA解析/トランスクリプトミクス市場について調査し、技術別、用途別、エンドユーザー別、および地域別の動向、市場に参入する主要企業のシェアとプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 発展
  • 市場セグメンテーション
    • 種類別
    • 用途別
    • エンドユーザー別
  • 市場動向
  • 促進因子
  • 阻害因子
  • 市場の機会
  • 主な課題

第6章 業界動向

  • イントロダクション
  • 業界動向
  • ポーターズファイブフォース分析
  • バリューチェーン
  • 戦略的ベンチマーキング

第7章 種類別市場

  • イントロダクション
  • マイクロアレイ
  • ポリメラーゼ連鎖反応(PCR)
  • シーケンシング技術
  • RNA遺伝子サイレンシング

第8章 用途別市場

  • イントロダクション
    • 臨床診断
    • 創薬
    • 毒性ゲノミクス

第9章 エンドユーザー別市場

  • イントロダクション
    • 学術研究機関、政府機関
    • 製薬会社・バイオテクノロジー企業
    • 病院・診断センター

第10章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第11章 企業プロファイル

第12章 競合環境

  • 市場シェア分析
  • 競合動向

第13章 付録

図表

目次
Product Code: BT 2766

The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing technological advancements in the field of sequencing technologies in transcriptomics research. Similarly, the increasing government and private funding for research coupled with research and development investments by the biotechnology companies are expected to drive the transcriptomics market. The increasing adoption of transcriptomics in the field of biomarker discovery opens new growth avenues with the rising preference of personalized medicine across the globe. However, the higher investment costs that restrict the adoption of transcriptomics products and dearth of skilled professionals are the factors hampering the growth of this market to a certain extent.

The transcriptomics market report covers the transcriptomic technologies, applications and end-users. The technologies market in this report is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology. Each of these technologies market is further sub-segmented into reagents, instruments and software. The applications of transcriptomics covered under the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics. The end-users of transcriptomics are pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers. This report also discusses the key market drivers, restraints, opportunities, challenges, and trends in the global transcriptomics market and its submarkets.

By 2019, North America will continue to dominate and drive the transcriptomics market, primarily due to the rising preference for personalized medicines which use biomarkers developed with the transcriptomic technologies. On the other hand, the market in Asia-Pacific region is expected to grow at a highest CAGR during the forecast period mainly due to the growing pharmaceutical and biotech industries in China and India. The reduction in funding for research and development coupled with decrease in the investment in research by the pharmaceutical and biotechnology companies in the European region as a means of cost containment is expected to hamper the growth of transcriptomics market in Europe.

The prominent players in the global trancriptomics market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).

Reasons to Buy the Report

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms to garner a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the transcriptomics market. The report analyzes the transcriptomics market by technology, application, end-user and geography covering North America, Europe, APAC, and RoW
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the transcriptomics market
  • Market Development: Comprehensive information on the lucrative emerging markets for transcriptomics market by technology, application, and end-user by product types
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the transcriptomics
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, manufacturing capabilities, and SWOT analyses of the leading players in the transcriptomics market

Table of Contents

1 Introduction

  • 1.1 Objectives of the Study
  • 1.2 Markets Covered
  • 1.3 Stakeholders
  • 1.4 Market Scope

2 Research Methodology

  • 2.1 Research Approach
  • 2.2 Market Size Estimation
  • 2.3 Market Crackdown and Data Triangulation
  • 2.4 Market Share Estimation
  • 2.5 Key Data From Secondary Sources
  • 2.6 Key Data From Primary Sources
    • 2.6.1 Key Industry Insights
  • 2.7 Assumptions for the Study

3 Executive Summary

4 Premium Insights

5 Market Overview

  • 5.1 Introduction
  • 5.2 Evolution
  • 5.3 Market Segmentation
    • 5.3.1 Transcriptomics Market, By Type
    • 5.3.2 Transcriptomics Market, By Application
    • 5.3.3 Global Transcriptomics Market, By End User
  • 5.4 Market Dynamics
  • 5.5 Key Market Drivers
    • 5.5.1 Growing Applications of Rna Sequencing in Transcriptomic Research to Drive Market Growth
    • 5.5.2 Increased Research and Development Spending By Biotechnology Companies to Boost RNA Analysis Market
    • 5.5.3 Increasing Preference for Personalized Medicine to Further Propel RNA AnalysisTechnologies Market
    • 5.5.4 Availability of Government and Private Funding to Drive Transcriptomic Technologies Market
  • 5.6 Key Market Restraints
    • 5.6.1 Need of High Capital Investment Limits Adoption of Transcriptomic Technologies
    • 5.6.2 Dearth of Skilled Professionals Hindering Greater Adoption of Transcriptomic Technologies
  • 5.7 Key Market Opportunities
    • 5.7.1 Significant Opportunities for Transcriptomic Technologies in the Field of Biomarker Discovery
    • 5.7.2 Emerging and Untapped Markets Present Opportunities
    • 5.7.3 Toxicogenomics As An Application to Open New Growth Avenues
  • 5.8 Key Challenges
    • 5.8.1 Lack of Effective Bioinformatics tools for Transcriptomic Analysis

6 Industry Trends

  • 6.1 Introduction
  • 6.2 Industry Trends
  • 6.3 Porter's Five forces Analysis
  • 6.4 Value Chain
  • 6.5 Strategic Benchmarking

7 Transcriptomics Technologies Market, By Type

  • 7.1 Introduction
  • 7.2 Microarrays
    • 7.2.1 Reagents
    • 7.2.2 Instruments
    • 7.2.3 Software
  • 7.3 Polymerase Chain Reaction (PCR)
    • 7.3.1 Reagents
    • 7.3.2 Instruments
    • 7.3.3 Software
  • 7.4 Sequencing Technologies
    • 7.4.1 Sanger Sequencing
      • 7.4.1.1 Reagents
      • 7.4.1.2 Instruments
      • 7.4.1.3 Software
    • 7.4.2 Next Generation Sequencing (NGS)
      • 7.4.2.1 Reagents
      • 7.4.2.2 Instruments
      • 7.4.2.3 Software
  • 7.5 RNAI Gene Silencing
    • 7.5.1 Reagents
    • 7.5.2 Instruments
    • 7.5.3 Software

8 Global Transcriptomics Market, By Application

  • 8.1 Introduction
    • 8.1.1 Clinical Diagnosis
    • 8.1.2 Drug Discovery
    • 8.1.3 Toxicogenomics

9 Global Transcriptomics Market, By End User

  • 9.1 Introduction
    • 9.1.1 Academic Research & Government Institutes
    • 9.1.2 Pharmaceutical & Biotechnology Companies
    • 9.1.3 Hospitals & Diagnostic Centers

10 Global Transcriptomics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 U.K.
    • 10.3.3 France
    • 10.3.4 Italy
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe (ROE)
  • 10.4 Asia-Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Rest of Asia-Pacific
  • 10.5 Rest of the World
    • 10.5.1 Latin America
    • 10.5.2 Middle East & Africa

11 Company Profiles

  • 11.1 Affymetrix Inc.
    • 11.1.1 Business Overview
    • 11.1.2 Products & Services
    • 11.1.3 Key Strategy
    • 11.1.4 Recent Developments
    • 11.1.5 SWOT Analysis
    • 11.1.6 MNM View
  • 11.2 Agilent Technologies, Inc.
    • 11.2.1 Business Overview
    • 11.2.2 Products & Services
    • 11.2.3 Key Strategy
    • 11.2.4 Recent Developments
    • 11.2.5 SWOT Analysis
    • 11.2.6 MNM View
  • 11.3 Bio-Rad Laboratories, Inc.
    • 11.3.1 Business Overview
    • 11.3.2 Products & Services
    • 11.3.3 Key Strategy
    • 11.3.4 Recent Developments
  • 11.4 GE Healthcare
    • 11.4.1 Business Overview
    • 11.4.2 Products & Services
    • 11.4.3 Key Strategy
    • 11.4.4 Recent Developments
  • 11.5 Illumina, Inc.
    • 11.5.1 Business Overview
    • 11.5.2 Products & Services
    • 11.5.3 Key Strategy
    • 11.5.4 Recent Developments
    • 11.5.5 SWOT Analysis
    • 11.5.6 MNM View
  • 11.6 Qiagen N.V.
    • 11.6.1 Business Overview
    • 11.6.2 Products & Services
    • 11.6.3 Key Strategy
    • 11.6.4 Recent Developments
    • 11.6.5 SWOT Analysis
    • 11.6.6 MNM View
  • 11.7 F. Hoffmann-La Roche Ltd.
    • 11.7.1 Business Overview
    • 11.7.2 Products & Services
    • 11.7.3 Key Strategy
    • 11.7.4 Recent Developments
  • 11.8 Sigma-Aldrich Corporation
    • 11.8.1 Business Overview
    • 11.8.2 Products & Services
    • 11.8.3 Key Strategy
    • 11.8.4 Recent Developments
  • 11.9 Thermo Fisher Scientific, Inc.
    • 11.9.1 Business Overview
    • 11.9.2 Products & Services
    • 11.9.3 Key Strategy
    • 11.9.4 Recent Developments
    • 11.9.5 SWOT Analysis
    • 11.9.6 MNM View
  • 11.10 Fluidigm Corporation
    • 11.10.1 Business Overview
    • 11.10.2 Products & Services
    • 11.10.3 Key Strategy
    • 11.10.4 Recent Developments

12 Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Share Analysis
  • 12.3 Competitive Situation and Trends

13 Appendix

  • 13.1 Insights of Industry Experts
  • 13.2 Available Customizations
  • 13.3 Related Reports
  • 13.4 Introducing RT: Real Time Market Intelligence

List of Tables

  • Table 1 Growing R&D Spending and Increasing Preference for Personalized Medicines to Fuel Growth of RNA Analysis Market
  • Table 2 Need of High Capital Investment and Dearth of Skilled Professionals May Limit Uptake of Transcriptomic Technologies
  • Table 3 Novel Biomarker Discovery and Toxicogenomics to Open New Growth Opportunities
  • Table 4 Lack of Effective Bioinformatics Tools Poses the Biggest Challenge for Transcriptomic
  • Table 5 Global Transcriptomics Market Size, By Technology, 2012-2019 ($Million)
  • Table 6 Global RNA Analysis Market Size, By Geography 2012-2019 ($Million)
  • Table 7 Global Transcriptomics Microarray Market Size, By Product, 2012-2019 ($Million)
  • Table 8 Global RNA Analysis Microarray Market Size, By Geography, 2012-2019 ($Million)
  • Table 9 Global Transcriptomic Microarray Reagents Market Size, By Geography, 2012-2019 ($Million)
  • Table 10 Global Transcriptomic Microarray Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 11 Global RNA Analysis Microarray Software Market Size, By Geography, 2012-2019 ($Million)
  • Table 12 Global Transcriptomics PCR Market Size, By Product, 2012-2019 ($Million)
  • Table 13 Global Transcriptomics PCR Market Size, By Geography, 2012-2019 ($Million)
  • Table 14 Global RNA Analysis PCR Reagents Market Size, By Geography, 2012-2019 ($Million)
  • Table 15 Global Transcriptomics PCR Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 16 Global Transcriptomics PCR Software Market Size, By Geography, 2012-2019 ($Million)
  • Table 17 Global RNA Analysis Sequencing Market Size, By Product, 2012-2019 ($Million)
  • Table 18 Global Transcriptomics Sequencing Market Size, By Geography, 2012-2019 ($Million)
  • Table 19 Global Transcriptomics Sanger Sequencing Market Size, By Product, 2012-2019 ($Million)
  • Table 20 Global RNA Analysis Sanger Sequencing Market Size, By Geography, 2012-2019 ($Million)
  • Table 21 Global Transcriptomic Sanger Sequencing Reagents Market Size, By Geography, 2012-2019 ($Million)
  • Table 22 Global RNA Analysis Sanger Sequencing Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 23 Global Transcriptomics Sanger Sequencing Software Market Size, By Geography, 2012-2019 ($Million)
  • Table 24 Global Transcriptomics NGS Market Size, By Product, 2012-2019 ($Million)
  • Table 25 Global RNA Analysis NGS Market Size, By Geography, 2012-2019 ($Million)
  • Table 26 Global Transcriptomics NGS Reagents Market Size, By Geography, 2012-2019 ($Million)
  • Table 27 Global Transcriptomics NGS Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 28 Global RNA Analysis NGS Software Market Size, By Geography, 2012-2019 ($Million)
  • Table 29 Global Transcriptomics RNAI Gene Silencing Market Size, By Product, 2012-2019 ($Million)
  • Table 30 Global Transcriptomics RNAI Gene Silencing Market Size, By Geography, 2012-2019 ($Million)
  • Table 31 Global Transcriptomics RNAI Gene Silencing Reagents Market Size, By Geography, 2012-2019 ($Million)
  • Table 32 Global Transcriptomics RNAI Gene Silencing Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 33 Global Transcriptomics RNAI Gene Silencing Software Market Size, By Geography, 2012-2019 ($Million)
  • Table 34 Global RNA Analysis Market Size, By Application, 2012-2019 ($Million)
  • Table 35 Global Transcriptomics Market Size for Clinical Diagnostics, By Geography, 2012-2019 ($Million)
  • Table 36 Global Transcriptomics Market Size for Drug Discovery, By Geography, 2012-2019 ($Million)
  • Table 37 Global Transcriptomics Market Size for Clinical Toxicogenomics, By Geography, 2012-2019 ($Million)
  • Table 38 Global RNA Analysis Market Size, By End User, 2012-2019 ($Million)
  • Table 39 Global Transcriptomics Market Size for Academic Research & Government Institutes, By Geography, 2012-2019 ($Million)
  • Table 40 Global Transcriptomics Market Size for Pharmaceutical & Biotechnology Companies, By Geography, 2012-2019 ($Million)
  • Table 41 Global Transcriptomics Market Size for Hospitals & Diagnostic Centers, By Geography, 2012-2019 ($Million)
  • Table 42 Global Transcriptomics Market Size, By Geography, 2012-2019 ($Million)
  • Table 43 North America: Transcriptomics Market Size, By Country, 2012-2019 ($Million)
  • Table 44 North America: Transcriptomics Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 45 North America: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 46 North America: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 47 North America: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 48 North America: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 49 North America: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 50 North America: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 51 North America: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 52 North America: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 53 U.S. : Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 54 U.S. : RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 55 U.S.: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 56 U.S.: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 57 U.S.: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 58 U.S.: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 59 U.S.: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 60 U.S.: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 61 U.S.: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 62 Canada : Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 63 Canada: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 64 Canada : Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 65 Canada: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 66 Canada : RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 67 Canada: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 68 Canada: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 69 Canada: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 70 Canada: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 71 Mexico: Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 72 Mexico: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 73 Mexico: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 74 Mexico: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 75 Mexico: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 76 Mexico: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 77 Mexico: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 78 Mexico: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 79 Mexico: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 80 Europe: Transcriptomics Market Size, By Country, 2012-2019 ($Million)
  • Table 81 Europe: Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 82 Europe: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 83 Europe: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 84 Europe: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 85 Europe: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 86 Europe: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 87 Europe: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 88 Europe: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 89 Europe: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 90 Germany: Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 91 Germany: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 92 Germany: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 93 Germany : Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 94 Germany: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 95 Germany: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 96 Germany: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 97 Germany: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 98 Germany: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 99 U.K.: Transcriptomics Market Size, By Product, 2012-2019 ($Million)
  • Table 100 U.K.: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 101 U.K.: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 102 U.K.: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 103 U.K.: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 104 U.K.: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 105 U.K.: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 106 U.K.: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 107 U.K.: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 108 France: Transcriptomics Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 109 France: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 110 France: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 111 France: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 112 France: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 113 France: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 114 France: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 115 France: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 116 France: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 117 Italy: Transcriptomics Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 118 Italy: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 119 Italy: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 120 Italy: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 121 Italy: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 122 Italy: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 123 Italy: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 124 Italy: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 125 Italy: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 126 Spain: Transcriptomics Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 127 Spain : RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 128 Spain: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 129 Spain: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 130 Spain: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 131 Spain: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 132 Spain: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 133 Spain: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 134 Spain: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 135 ROE: Transcriptomics Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 136 ROE: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 137 ROE: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 138 ROE: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 139 ROE: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 140 ROE: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 141 ROE: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 142 ROE: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 143 ROE: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 144 Asia-Pacific: Transcriptomics Market Size, By Country, 2012-2019 ($Million)
  • Table 145 Asia-Pacific: Transcriptomics Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 146 Asia-Pacific: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 147 Asia-Pacific: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 148 Asia-Pacific: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 149 Asi-Pacific: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 150 Asia-Pacific: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 151 Asia-Pacific: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 152 Asia-Pacific: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 153 Asia-Pacific: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 154 China: Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 155 China: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 156 China: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 157 China: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 158 China: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 159 China: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 160 China: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 161 China: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 162 China: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 163 Japan: Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 164 Japan: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 165 Japan: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 166 Japan: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 167 Japan: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 168 Japan: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 169 Japan: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 170 Japan: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 171 Japan: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 172 India: Transcriptomics Market Size, By Type, 2012-2019 ($Million)
  • Table 173 India: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 174 India: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 175 India: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 176 India: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 177 India: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 178 India: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 179 India: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 180 India: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 181 ROAPAC: Transcriptomics Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 182 ROAPAC: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 183 ROAPAC: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 184 ROAPAC: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 185 ROAPAC: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 186 ROAPAC: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 187 ROAPAC: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 188 ROAPAC: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 189 ROAPAC: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 190 ROW: Transcriptomics Market Size, By Region, 2012-2019 ($Million)
  • Table 191 ROW: Transcriptomics Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 192 ROW: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 193 ROW: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 194 ROW: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 195 ROW: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 196 ROW: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 197 ROW: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 198 ROW: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 199 ROW: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 200 Latin America: Transcriptomics Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 201 Latin America: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 202 Latin America: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 203 Latin America: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 204 Latin America: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 205 Latin America: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 206 Latin America: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 207 Latin America: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 208 Latin America: Transcriptomics Market Size, By End User, 2012-2019 ($Million)
  • Table 209 Middle East & Africa: Transcriptomics Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 210 Middle East & Africa: RNA Analysis Microarray Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 211 Middle East & Africa: Transcriptomics PCR Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 212 Middle East & Africa: Transcriptomics Sequencing Technologies Market Size, By Type, 2012-2019 ($Million)
  • Table 213 Middle East & Africa: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 214 Middle East & Africa: Transcriptomics NGS Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 215 Middle East & Africa: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012-2019 ($Million)
  • Table 216 Middle East & Africa: Transcriptomics Market Size, By Application, 2012-2019 ($Million)
  • Table 217 Middle East & Africa: Transcriptomics Market Size, By End User, 2012-2019 ($Million)

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 3 Bottom-Up Approach
  • Figure 4 Top-Down Approach
  • Figure 5 Data Triangulation Methodology
  • Figure 6 Technological Advancements to Play Vital Role in the Omics Industry
  • Figure 7 Market Segmentation: By Type
  • Figure 8 Global Market: By Application
  • Figure 9 Global Market, By End User
  • Figure 10 Key Market Dynamics
  • Figure 11 Affymetrix Inc. : Company Snapshot
  • Figure 12 Agilent Technologies Inc. : Company Snapshot
  • Figure 13 Bio-Rad Laboratories Inc.: Company Snapshot
  • Figure 14 General Electric Co. : Company Snapshot
  • Figure 15 Illumina Inc. : Company Snapshot
  • Figure 16 Qiagen N.V.: Company Snapshot
  • Figure 17 F. Hoffmann-La Roche Ltd : Company Snapshot
  • Figure 18 Sigma Aldrich: Company Snapshot
  • Figure 19 Thermofisher Scientific Inc. : Company Snapshot
  • Figure 20 Fluidigm Corporation: Company Snapshot
Back to Top